| Literature DB >> 20491646 |
A Zouhair1, M Ozsahin, M Schaffer, S Albrecht, F Camus, P Jichlinski, R-O Mirimanoff, A Bischof Delaloye, J-Y Meuwly, J O Prior.
Abstract
Positron emission computed tomography (PET) is a functional, noninvasive method for imaging regional metabolic processes that is nowadays most often combined to morphological imaging with computed tomography (CT). Its use is based on the well-founded assumption that metabolic changes occur earlier in tumors than morphologic changes, adding another dimension to imaging. This article will review the established and investigational indications and radiopharmaceuticals for PET/CT imaging for prostate cancer, bladder cancer and testicular cancer, before presenting upcoming applications in radiation therapy.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20491646 DOI: 10.2174/092986710791556014
Source DB: PubMed Journal: Curr Med Chem ISSN: 0929-8673 Impact factor: 4.530